Cantitate/Preț
Produs
Total produse
Vezi coșul
Multiple System Atrophy de Gregor K. Wenning

Multiple System Atrophy

Editat de Gregor K. Wenning, Alessandra Fanciulli
en Limba Engleză Hardback – 24 sep 2013
This textbook provides a comprehensive monography on multiple system atrophy (MSA), a rare and fatal neurodegenerative disorder that presents with autonomic failure and either parkinsonism (MSA-P) or cerebellar ataxia (MSA-C).The underlying neuropathology of MSA is characterized by striatonigral degeneration (SND), olivopontocerebellar atrophy (OPCA) and unique oligodendroglial cytoplasmic alpha-synuclein inclusions. MSA is therefore classified among the alpha-synucleinopathies such as Parkinson`s disease, pure autonomic failure and dementia with Lewy bodies. Over the last decade there have been important advances in early diagnosis, pathogenesis research and clinical trial activity. The monography will cover the entire spectrum ranging from molecular and genetic work to symptomatic and interventional therapies. The book is written for movement disorder clinicians and basic neuroscientists interested in degenerative movement disorders.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 75874 lei  6-8 săpt.
  SPRINGER VIENNA – 23 aug 2016 75874 lei  6-8 săpt.
Hardback (1) 70716 lei  6-8 săpt.
  SPRINGER VIENNA – 24 sep 2013 70716 lei  6-8 săpt.

Preț: 70716 lei

Preț vechi: 74439 lei
-5% Nou

Puncte Express: 1061
Preț estimativ în valută:
13532€ • 14236$ • 11233£

Carte tipărită la comandă

Livrare economică 15-29 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783709106860
ISBN-10: 3709106869
Pagini: 198
Ilustrații: XVI, 198 p. 33 illus., 20 illus. in color.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.57 kg
Ediția:2014
Editura: SPRINGER VIENNA
Colecția Springer
Locul publicării:Vienna, Austria

Public țintă

Professional/practitioner

Cuprins

1. Historical Review.- 2. Epidemiology.- 3. Neuropathology.- 4. Etiopathogenesis.- 5. Animal Models.- 6. Clinical Presentation.- 7. Clinical diagnostic Criteria.- 8. Natural History.- 9. Investigations.- 10. Tratment.

Recenzii

From the reviews:
“This book summarizes what is currently known about multiple system atrophy. … The indented audience is both neurology clinicians and neuroscientists who specialize in degenerative movement disorders, but the book also may serve as an additional source of reference for general neurologists or any physicians involved in the treatment of patients with these disorders. … Since it comprises what is currently known about multiple system atrophy, degenerative movement disorder neurologists and neuroscientists should consider this a valuable resource for their clinical practice and research.” (Pawel Tacik, Doody’s Book Reviews, January, 2014)

Notă biografică

Professor Gregor K. Wenning graduated from Münster University in 1991. He trained in Neurology at the University Hospitals of Tübingen, London and Innsbruck. He started his scientific career at the Institute of Neurology in London where he performed a series of clinicopathological and experimental studies on multiple system atrophy (MSA). He received a PhD from the University of London in 1996. Since 1999 he has served as Consultant Neurologist and Assistant Professor at the Parkinson Centre of the Department of Neurology at the Medical University Innsbruck. In 2006 he became a full Professor at the Medical University of Innsbruck and head of the newly created Division of Clinical Neurobiology devoted exclusivley to MSA research. Together with Professor Werner Poewe he initiated the European MSA Study Group in 1999. EMSA-SG generated the first validated assessment tool for MSA (Unified MSA Rating Scale – UMSARS), it also conducted a large natural history study in 12 European countries and Israel, and currently performs genomic studies as well as phase II intervention trials. Professor Wenning has published more than 200 original papers, reviews and invited book chapters on MSA and related parkinsonian disorders. He was a member of the German Scholarship Foundation, fellow of the UK Parkinson`s Disease Society, first recipient of the Birkmayer prize in 1998 and also first recipient of the Oppenheimer prize in 2004 for recognition of his work on MSA.


Dr. Alessandra Fanciulli graduated with distinction from the Sapienza University of Rome in 2010. She started her scientific career in Rome working on cardiovascular autonomic failure in neurodegenerative diseases. Since 2012 she has been a clinical research fellow at the Division of Neurobiology, Innsbruck Medical University and currently performs clinical research projects on multiple system atrophy and Parkinson's disease. In 2013 Dr. Fanciulli was awarded with theresearch prizes of the LIMPE - Lega italiana per la lotta contro la malattia di Parkinson and ÖPG - Österreichische Parkinson Gesellschaft.

Textul de pe ultima copertă

This textbook provides a comprehensive monography on multiple system atrophy (MSA), a rare and fatal neurodegenerative disorder that presents with autonomic failure and either parkinsonism (MSA-P) or cerebellar ataxia (MSA-C).The underlying neuropathology of MSA is characterized by striatonigral degeneration (SND), olivopontocerebellar atrophy (OPCA) and unique oligodendroglial cytoplasmic alpha-synuclein inclusions. MSA is therefore classified among the alpha-synucleinopathies such as Parkinson`s disease, pure autonomic failure and dementia with Lewy bodies. Over the last decade there have been important advances in early diagnosis, pathogenesis research and clinical trial activity. The monography will cover the entire spectrum ranging from molecular and genetic work to symptomatic and interventional therapies. The book is written for movement disorder clinicians and basic neuroscientists interested in degenerative movement disorders.

Caracteristici

Provides complete insight into onset, progression, diagnoses and therapy of MSA Summarizes the important advances gained in the last years in MSA research Describes novel findings in MSA research and its therapies